Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Degenerations”

2,025 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,025 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT01790958
What this trial is testing

Microcurrent Stimulation to Treat Macular Degeneration

Who this might be right for
Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
Retina Institute of Hawaii 50
Not applicableUnknownNCT04808804
What this trial is testing

Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected by Optical Coherence Tomography

Who this might be right for
Retinal NeuropathyNeurodegeneration
Assiut University 80
Early research (Phase 1)Looking for participantsNCT04289571
What this trial is testing

Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Who this might be right for
Cone-Rod DegenerationRod-Cone Degeneration
National Eye Institute (NEI) 165
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Testing effectiveness (Phase 2)Study completedNCT05712148
What this trial is testing

Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaStem Cell Transplant
Acibadem University 15
Not applicableLooking for participantsNCT04847635
What this trial is testing

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Who this might be right for
Macular Degeneration, SenileLaser Burn of RetinaMacular Degeneration Intermediate+1 more
Ospedale San Raffaele 50
Early research (Phase 1)Study completedNCT00346853
What this trial is testing

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Who this might be right for
Macular Dystrophy, Corneal
University of Utah 10
Not applicableStudy completedNCT02279537
What this trial is testing

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Who this might be right for
Wet Macular Degeneration
Bayer 593
Not applicableStudy completedNCT01568021
What this trial is testing

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 100
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Not applicableWithdrawnNCT05675917
What this trial is testing

MacuTest Website for Personalized AMD Risk Prediction and Prevention

Who this might be right for
Macular Degeneration
University Hospital, Bordeaux
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Not applicableActive Not RecruitingNCT04285398
What this trial is testing

Prospective Natural History Study of Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
SparingVision 82
Early research (Phase 1)Ended earlyNCT00102115
What this trial is testing

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Light Sciences LLC 27
Post-approval studies (Phase 4)Study completedNCT02392364
What this trial is testing

Variable Interval Versus Set Interval Aflibercept for DME

Who this might be right for
Cystoid Macular EdemaDiabetic Macular Edema
California Retina Consultants 50
Not applicableUnknownNCT06224114
What this trial is testing

Coloured-light in Retinitis Pigmentosa.

Who this might be right for
Retinitis Pigmentosa
University College, London 70
Not applicableActive Not RecruitingNCT06351033
What this trial is testing

Ozonized Oil as Dietary Supplement in Macular Degeneration

Who this might be right for
Maculopathy
Alba Di Pardo 60
Load More Results